Vetophage is the 1st French company specializing in the use of phages for animal health
Vetophage is able to provide phages and effective solutions to fight pathogenic bacteria including those resistant to antibiotics. In addition to its specific know-how, Vetophage possesses two large collections of phages: Staphylococcus aureus and Vibrio paraheamolyticus. Their effects are verified in many sectors such as bovine mastitis and aquaculture among others.
499t
of antibiotics intended for animal health were sold in France in 2017.95% of these antibiotics were administered to animals intended for human consumption.
Figures published by Santé publique France
"Antibiotic resistance represents today, one of the most serious threats to global health, food security and development. "
— WHO, World Health Organization
Antibiotic resistance: a global problem
Bacteria know no borders and so each country has its global responsibility. Beyond its geographical aspect, antibiotic resistance affects all living beings: humans, animals and the environment. This is the ‘One Health’ concept: We are a single, interconnected health system and if any of these three pillars are destabilized, the whole tripod collapses. Across the world, antibiotic resistance is accelerated by the consumption of antibiotics by livestock and their active ingredients released into the environment.
12500
deaths per year in France due to antimicrobial resistance
700000
deaths per year worldwide due to antimicrobial resistance
10000000
in 2050, it is estimated that antibioresistance will cause 10,000,000 deaths annually
There is a wide range of applications. Vetophage is developing a rapid detection kit and a phage cocktail to fight bovine mastitis, which affects 25% of the cows in Europe.
Vetophage innovations are recognized
2017
Obtaining the grant
French Tech Emergence
2018
Winner of the competition
R&D Booster
2019
Obtaining the label
French Tech Seed
